Trevi Therapeutics, Inc. — All Filings
513 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
3
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
RW
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | CHANGES IN BENEFICIAL OWNERSHIP | 0001387131-22-005629 | May 2, 2022 | Apr 28, 2022 |
| DEF 14A | DEF 14A | 0001564590-22-016859 | Apr 29, 2022 | Jun 23, 2022 |
| SC 13D/A | NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS -- SCHEDULE 13D/A3 | 0001072613-22-000390 | Apr 25, 2022 | — |
| SC 13G | SC 13G | 0001104659-22-048379 | Apr 21, 2022 | — |
| SC 13G | SC 13G | 0001104659-22-048154 | Apr 21, 2022 | — |
| D | — | 0001563880-22-000001 | Apr 18, 2022 | — |
| SC 13G | SC 13G | 0001193125-22-107726 | Apr 18, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-024323 | Apr 13, 2022 | Apr 11, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-024322 | Apr 13, 2022 | Apr 11, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-024321 | Apr 13, 2022 | Apr 11, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-024320 | Apr 13, 2022 | Apr 11, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-024319 | Apr 13, 2022 | Apr 11, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-024318 | Apr 13, 2022 | Apr 11, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-024315 | Apr 13, 2022 | Apr 11, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-024314 | Apr 13, 2022 | Apr 11, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-024307 | Apr 13, 2022 | Apr 11, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-024301 | Apr 13, 2022 | Apr 11, 2022 |
| SC 13G | MAI 13G | 0001040197-22-000003 | Apr 8, 2022 | — |
| 8-K | 8-K | 0001193125-22-098229 | Apr 7, 2022 | Apr 6, 2022 |
| 10-K | 10-K | 0001564590-22-010875 | Mar 17, 2022 | Dec 31, 2021 |
| 8-K | 8-K | 0001564590-22-010864 | Mar 17, 2022 | — |
| 8-K | 8-K | 0001564590-22-010637 | Mar 16, 2022 | — |
| SC 13G | SC 13G | 0001104659-22-031938 | Mar 9, 2022 | — |
| SC 13G | SC 13G | 0001019056-22-000268 | Mar 9, 2022 | — |
| 8-K | 8-K | 0001564590-22-006498 | Feb 24, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-009739 | Feb 15, 2022 | Feb 11, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-009738 | Feb 15, 2022 | Feb 11, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-009734 | Feb 15, 2022 | Feb 11, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-009733 | Feb 15, 2022 | Feb 14, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-009743 | Feb 15, 2022 | Feb 11, 2022 |
| SC 13G | SC 13G | 0001193125-22-042215 | Feb 14, 2022 | — |
| SC 13G/A | AMENDMENT TO FORM SC 13G | 0001387131-22-001690 | Feb 11, 2022 | — |
| 8-K | 8-K | 0001564590-22-003250 | Feb 1, 2022 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-018305 | Jan 26, 2022 | — |
| 3 | FORM 3 - TREVI THERAPEUTICS INC. | 0001387131-22-000606 | Jan 21, 2022 | Jan 12, 2022 |
| 8-K | 8-K | 0001564590-22-001365 | Jan 14, 2022 | Jan 10, 2022 |
| 8-K | 8-K | 0001564590-22-000348 | Jan 5, 2022 | — |
| EFFECT | — | 9999999995-21-004369 | Nov 16, 2021 | — |
| CORRESP | — | 0001193125-21-328039 | Nov 12, 2021 | — |
| 8-K | 8-K | 0001564590-21-056180 | Nov 10, 2021 | — |
| UPLOAD | — | 0000000000-21-013643 | Nov 10, 2021 | — |
| 10-Q | 10-Q | 0001564590-21-056183 | Nov 10, 2021 | Sep 30, 2021 |
| S-3 | S-3 | 0001193125-21-321577 | Nov 5, 2021 | — |
| SC 13D/A | NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS -- SCHEDULE 13D/A2 | 0001072613-21-000615 | Nov 2, 2021 | — |
| EFFECT | — | 9999999995-21-004024 | Oct 25, 2021 | — |
| D | — | 0001563880-21-000003 | Oct 21, 2021 | — |
| CORRESP | — | 0001193125-21-303975 | Oct 21, 2021 | — |
| UPLOAD | — | 0000000000-21-012778 | Oct 21, 2021 | — |
| D | — | 0001563880-21-000001 | Oct 20, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-21-061097 | Oct 19, 2021 | Oct 18, 2021 |